As leading contract research organization we provide research and development services to our customers and partners from industry, other research organizations and universities for more than 30 years. Transferring requirements into workable and customer friendly solutions we secure a competitive edge and head start in innovation. Based on our profound experience in microsystem technology we accept challenges others don’t due to a lack of knowledge/experience or interest.
With our project work we contribute to the Fraunhofer Strategic Research Fields of Hydrogen Technologies, Resource Efficiency and Climate Technologies, Digital Healthcare and Bioeconomy.
NEWS
Webnews
Single-Cell Isolation and Ejection from Microfluidic Cell Traps for High-Resolution Bioprinting
We congratulate Klaus Kögler on the successful defense of his doctoral theses in the field of bioprinting.
Fraunhofer IMM showcasies the latest developments in on-site multi-ion monitoring for on-line nutrient-laden water control in vertical hydroponic systems.
Visit us in Hall A3 Booth 312 at the Fraunhofer joint booth.
Fraunhofer IMM Presents Innovative Hydrogen Technologies at Hyvolution 2026
The three-day leading event for the hydrogen sector will take place from January 27 to 29, 2026, at Paris Expo Porte de Versailles. The Fraunhofer IMM team welcomes the trade visitors in Hall 1 at Booth N47.
Green methanol and DME competitive in the medium term
The Fraunhofer IEE and its project partners have developed key technological, economic, and systemic foundations for the sustainable production of green hydrogen and its derivatives methanol and dimethyl ether (DME) in Chile.
FlowDLS: Real-time precision in nanoparticle analysis
With flowDLS, Fraunhofer IMM has developed a system based on dynamic light scattering (DLS) that measures particle sizes in real time. What makes flowDLS special?
Read more in our Newsletter "FlowDLS: Real-time precision in nanoparticle analysis".
A minimally Invasive Solution for Quick and Easy Determination of Blood Potassium Levels
In collaboration with French start-up Ki'tech, researchers at the IMM want to revolutionize patient monitoring with a minimally invasive solution that measures biomarkers, including potassium, in the subcutaneous interstitial fluid.